Pediatric Pulmonary Vascular Disease or Adult Pulmonary Vascular Disease

Anti-fibroblast and anti-endothelial cell autoantibodies in pulmonary arterial hypertension (PAH) in patients with connective tissue diseases (CTD)

Benjamin Thoreau, Arthur Ranaud, Philippe Chafey, Guilhem Clary, Morgane La Gall, Cédric Broussard, Odile Launay, David Launay, Eric Hachulla, Christophe Deligny, Alban-Elouen Baruteau, Anaïs Vallet-Pichard, Benjamin Chaigne, Azzeddine Yaici, Oliver Sitbon, David Montani, Marc Humbert, Luc MouthonUniversité Paris Cité. Hôpital Cochin and Assistance Publique-Hôpitaux de Pari. de l’Est et de l’Ouest. Hôpital Pierre Zobda-Quitman. Nantes […]

Anti-fibroblast and anti-endothelial cell autoantibodies in pulmonary arterial hypertension (PAH) in patients with connective tissue diseases (CTD) Read More »

Pulmonary vascular complications of cirrhosis: hepatopulmonary syndrome and portopulmonary hypertension

Maïté Verstraeten, Sander Lefere, Sarah RaevensGhent University Hospital and Ghent University.Belgium Acta Clinica BelgicaActa Clin Belg 2025; DOI: 10.1080/17843286.2025.2456697 AbstractHepatopulmonary syndrome (HPS) and portopulmonary hypertension (POPH) are two distinct pulmonary vascular complications seen in patients with liver disease and/or portal hypertension. HPS is characterized by disturbed gas exchange and hypoxemia because of intrapulmonary vascular dilatations. POPH

Pulmonary vascular complications of cirrhosis: hepatopulmonary syndrome and portopulmonary hypertension Read More »

The Role of Imaging in Pulmonary Vascular Disease: The Clinician’s Perspective

Brandon R. Jakubowski, Megan Griffiths, Kara N. GossUniversity of Texas Southwestern Medical Center.United States Radiology Clinics of North AmericaRadiol Clin North Am 2025; 63: 305-313DOI: 10.1016/j.rcl.2024.07.008 AbstractPulmonary vascular diseases, particularly when accompanied by pulmonary hypertension, are complex disorders often requiring multimodal imaging for diagnosis and monitoring. Echocardiography is the primary screening tool for pulmonary hypertension, while

The Role of Imaging in Pulmonary Vascular Disease: The Clinician’s Perspective Read More »

Targeting Lung Heme Iron by Aerosol Hemopexin Administration in Sickle Cell Disease Pulmonary Hypertension

Melissa Lucero, Christina Lisk, Francesca Cendali, Delaney Swindle, Saini Setua, Kiruphagaran Thangaraju, David I. Pak, Quinton O’Boyle, Shuwei Lu, Robert Tolson, Seth Zaeske, Nishant Rana, Saqib Khan, Natalie Westover, Pavel Davizon Castillo, Gemlyn George, Kathryn Hassel, Rachelle Nuss, Nathan Brinkman, Thomas Gentinetta, Andre F. Palmer, Angelo D’Alessandro, Paul W. Buelher, David C. IrwinUniversity of Colorado,

Targeting Lung Heme Iron by Aerosol Hemopexin Administration in Sickle Cell Disease Pulmonary Hypertension Read More »

The clinical assessment of lung involvement in patients with Still’s disease, results from the multicentre international AIDA Network Still’s Disease Registry

Piero Ruscitti, Antonio Vitale, Ilenia Di Cola, Valeria Caggiano, Pierpaolo Palumbo, Ernesto Di Cesare, Andrea Hinojosa-Azaola, Jiram Torres-Ruiz, Guillermo Arturo, Guaracha-Basañez, Eduardo Martín-Nares, Giuseppe Lopalco, Maria Morrone, Florenzo Iannone, Henrique A. Mayrink Giardini, Rafael Alves Cordeiro, Isabele, Parente de Brito Antonelli, Onorina Berardicurti, Luca Navarini, Francesco Ciccia, Maria Chiara Visconti, Daniela Iacono, Haner Direskeneli, Sukran

The clinical assessment of lung involvement in patients with Still’s disease, results from the multicentre international AIDA Network Still’s Disease Registry Read More »

Novel Therapies for Right Ventricular Failure

Bibhuti B. DasUniversity of Mississippi Medical Center.United States Current Cardiology ReportsCurr Cardiol Rep 2025; 27:DOI: 10.1007/s11886-024-02157-9 AbstractPurpose of review: Traditionally viewed as a passive player in circulation, the right ventricle (RV) has become a pivotal force in hemodynamics. RV failure (RVF) is a recognized complication of primary cardiac and pulmonary vascular disorders and is associated with a

Novel Therapies for Right Ventricular Failure Read More »

Reversed valved Potts shunt for refractory primary pulmonary arterial hypertension

Sebastian Michel, Joseph Pattathu, Jürgen Hörer, Fabian A. KariLMU University Hospital. Gernany Multimedia Manual of Cardio-thoracic SurgeryMultimed Man Cardiothorac Surg 2025; DOI: 10.1510/mmcts.2024.120 AbstractThis procedure is carried out via a full sternotomy using standard aortic and bicaval cannulations. For the aortic and pulmonary anastomoses, selective antegrade unilateral cerebral perfusion is used after cooling the body temperature

Reversed valved Potts shunt for refractory primary pulmonary arterial hypertension Read More »

Precision Medicine for Pulmonary Vascular Disease: The Future Is Now (2023 Grover Conference Series)

Lindsay M. Forbes, Natalie Bauer, AritraBhadra, Stefan Gräf, GustavoA.Heresi, Rachel K. Hopper, Harm J. Bogaard, Gaurav Choudhary, Kara N. Goss, Arun Jose, Yunhye Kim, Timothy Klouda, Tim Lahm, Allan Lawrie, Peter J. Leary, Jane A. Leopold, Suellen D. Oliveira, Christopher J. Rhodes, Duncan J. Stewart, Rebecca R. Vanderpool, Sasha Z. Prisco, Ruslan Rafikov, Ke Yuan,

Precision Medicine for Pulmonary Vascular Disease: The Future Is Now (2023 Grover Conference Series) Read More »

Diagnostic enigma of pulmonary hypertension: Tale from a series of three patients

Anil Kumar Singhi, Anup Banerji, Nandini Biswas, Soumen DasMedica Super Specialty Hospital. India Medical Journal Armed Forces IndiaMed J Armed Forces Ind 2024; 80 (Suppl 1): S320-S324DOI: 10.1016/j.mjafi.2023.08.003 AbstractPulmonary hypertension (PH) is a complex condition with multiple etiological factors. The ability to identify a potential underlying cause is crucial for accurate diagnosis, patient management, and prognostication.

Diagnostic enigma of pulmonary hypertension: Tale from a series of three patients Read More »

Update on Eisenmenger syndrome – Review of pathophysiology and recent progress in risk assessment and management

Ranjan Banerjee, Alexander R. OpotowskyCincinnati Children’s Hospital and University of Cincinnati College of MedicineUnited States International Journal of Cardiology Congenital Heart DiseaseInt J Cardiol Congenit Heart Dis 2024; DOI: 10.1016/j.ijcchd.2024.100520 AbstractLongstanding left-to-right shunting associated with congenital heart disease (CHD) can ultimately lead to pulmonary vascular remodeling, pulmonary arterial hypertension, and shunt reversal, the hallmark feature of

Update on Eisenmenger syndrome – Review of pathophysiology and recent progress in risk assessment and management Read More »

Scroll to Top